Preventive Medicine & Public Health

Haluskova Balter Ivana , MD,MBA, France French Medical ID professional specialized in infectious diseases, internal medicine, certified in Immunology and Pediatric, MBA vaccinology and years of clinical practice. Certified in Health and Diplomacy with Lived multi-country medical “field “experience in Southeast Asia (India in particular), West/Central/East Europe. Over 17 years of experience in senior medical lead positions in pharmaceutical research. Member of World alliance against antibiotic resistance and French immunology society (SFI) administrative boards and several international academic societies with focus at innovation of R&D. reflecting immunology and genetic variability, role of immunologic approach for treatment and diagnostic to tackle problem of resistance and role of microbiota to empower host immune response with extensive clinical application. Member of international advisory group (CHD India) in order to attract attention to crucial importance of health issues for sustainable economic development and security. Years of expertise to work on project related to global health more focused at Eurasia and Asia (India in particular)

Preventive Medicine and Public Health, Vaccine, HealthCare

Azadeh Stark is a cancer and molecular epidemiologist and holds the position of senior scientist at the Department of Pathology at Henry Ford Health System, Professor-in-Practice at the School of Interdisciplinary Studies at the University of Texas at Dallas and Visiting Research Professor at the School of Nursing, Chiang Mai International University in Thailand. She has authored and co-authored more than 35 peer-reviewed manuscripts and three book chapters. Dr. Stark believes the best science and the most effective population health interventions result from constructive interdisciplinary collaboration. She has been an active participant in various community health improvement projects.

Breast cancer, Racial Disparity in Cancer Treatment Outcomes, Lung Cancer, Ovarian Cancer

Dr. Ipseeta Menon is presently working as Professor, Dept of Public Health Dentistry, in ITS Dental College, Ghaziabad. She completed BDS in 1998 from Bangalore University and MDS in 2009 from Rohil-Khand University, Bareilly. She has attended and presented papers in many National and International Conferences. She was a key participant in National Oral Health Survey, to estimate Dental Health & Manpower & Disease Prevalence in urban and rural India” as a part of the Delhi/NCR team held in 2010. She has authored a book in her specialty. She has many National and International publications to her credit. She is in the editorial board for many National Journals and reviewer for reputed International Journals. She has won many laurels in the field of Public Health Dentistry. She was awarded the Excellence in PUBLIC HEALTH DENTISTRY AWARD - Indian Health Professional Award in 2017.

Preventive Medicine, Public Health Dentistry

Andreas was born and raised in South Africa, a country with a rich heritage in outdoor living and healthy lifestyle tradition. After qualifying as a medical doctor in 1992 he worked as a General Practitioner with a special interest in treating Chronic Fatigue and during his specialist training he participated in psycho-immunology research. He has maintained his longstanding interest in all areas of Lifestyle Medicine, particularly exercise and nutrition, since taking up his first position as a Consultant Psychiatrist in 2000.

Eating Disorders, Post Traumatic Stress Disorder, Anxiety and Depressive Disorders, Psychosomatic Conditions, Occupational Mental Health, Medical-Legal Psychiatry.

Prof. Franco obtained his MD at Pontificia Universidad Javeriana, Bogotá in 1998. He moved to the Netherlands to complete MSc and DSc degrees in clinical epidemiology and a PhD in public health and cardiovascular disease prevention (2005) at the Erasmus University Medical Center. Following a postdoc at Erasmus MC, he moved to the UK where he was a senior public health epidemiologist at Unilever England, assistant professor of public health at the University of Warwick, and then director of the MPhil program and clinical lecturer in public health at the University of Cambridge.

Preventive Medicine, Epidemiology, Public Health, Cardiovascular disease prevention, Ageing research

David Ross was commissioned into the Royal Army Medical Corps in 1983 and graduated in medicine from St Bartholomew’s Hospital, London in 1986. In 2012 he was appointed the Parkes Professor of Preventive Medicine and in 2014 an Honorary Queen’s Physician. He has been associated with MASTA, a travel medicine provider, circa 2005 and from 2012 has been their Consultant Medical Advisor. Recent travel medicine research interests have included malaria prevention and tuberculosis screening. David is also Deputy Chief Examiner of the Diploma in Medical Care of Catastrophes at the Society of Apothecaries and an examiner at the UK Faculty of Public Health.

Preventive Medicine, Public Health, Travel Medicine

Sergey Suchkov was born in the City of Astrakhan, Russia. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Inst of Med Enzymology. In 2001, and then his Doctor Degree at the Nat Inst of Immunology in Russia. From 1989 through 1995, was being a Head of the Lab of Clin Immunology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004 - a Chair of the Dept for Clin Immunology, Moscow Clin Research Institute (MONIKI). In 1993-1996, was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is: ● Professor, Director, Center for Personalized Medicine, Sechenov University and Dept of Clinical Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Professor, Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. Dr Suchkov is a member of the: ● New York Academy of Sciences, USA ● American Chemical Society (ACS), USA; ● American Heart Association (AHA), USA; ● European Association for Medical Education (AMEE), Dundee, UK; ● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ● ARVO (American Association for Research in Vision and Ophthalmology); ● ISER (International Society for Eye Research); ● Personalized Medicine Coalition (PMC), Washington, DC, USA Dr Suchkov is a member of the Editorial Boards of “Open Journal of Immunology”, EPMA J., American J. of Cardiovascular Research and “Personalized Medicine Universe”

Personalized and Precision Medicine,Translational Medicine, Preventive Medicine

Dr. Masako Morishita is an Associate Professor in the Department of Family Medicine, College of Human Medicine at Michigan State University (MSU). She is an environmental exposure scientist, focused on improving physicochemical characterization of indoor/outdoor airborne particles, quantification of biomarkers of trace metals, and emission source identification – all of which is essential for toxicological and epidemiological studies in public health. Until recently she led exposure assessment tasks in the Great Lakes Air Center for Integrated Environmental Research (funded by USEPA), and directed the Trace Metals Laboratory for the University of Michigan Environmental Health Sciences Core Center (funded by NIEHS). She now directs the newly-constructed MSU Exposure Science Laboratory. She is currently the PI of an NINR R01 project, conducting a community-based intervention study focusing on the reduction of personal PM2.5 exposure and adverse cardiovascular responses. She received her B.S. in chemical engineering and her M.S. and Ph.D. in environmental health sciences from the University of Michigan.

Environmental Health Science, Preventive Medicine, Health Care

Vera Simovska is University Professor for Hygiene of Nutrition, Medical Dietetics and Health Management at the MIT University-Skopje. Prior to that, she was the founding director of the Master Studies for Nutrition, and Food Quality and Safety at the University of Bitola from 2012 to 2015. She was also a member of the Macedonian Committee for Health Promotion and an expert in the Ministry of Health from 2002 to 2011. From 2005, she is the first President of the National organization for the promotion of health-enhancing physical activity “HEPA Macedonia” which is a member of the WHO HEPA Europe. She was a National coordinator of several programs covered by the World Health Organization and an independent expert of the European Commission (FP7, HORIZON2020). Dr. Simovska research is focused in the area of public health nutrition, physical activity, obesity, cardiometabolic risk, and the NCD prevention and health promotion strategies and programs. She is the author of published academic books and chapters and over 100 original scientific articles.

Public Health Nutrition, Physical Activity, Obesity

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

r. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

Prof. Dr. Carol Thomson, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Genetics, Virology and Immunology at California South University (CSU), Irvine, California, USA. He is a British scientist, who along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, co-discovered Hepatitis B in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of Hepatitis B led to the rapid development of diagnostic reagents to detect HCV in blood supplies which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide. Prof. Dr. Carol Thomson is currently America Excellence Research Chair in Virology and Li Ka Shing Professor of Virology at the California South University (CSU) where he is also Director of the Li Ka Shing Applied Virology Institute.

Genetics, Health Care, Medicine

Sergey Suchkov was born in the City of Astrakhan, Russia. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Inst of Med Enzymology. In 2001, and then his Doctor Degree at the Nat Inst of Immunology in Russia. From 1989 through 1995, was being a Head of the Lab of Clin Immunology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004 - a Chair of the Dept for Clin Immunology, Moscow Clin Research Institute (MONIKI). In 1993-1996, was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is: ● Professor, Director, Center for Personalized Medicine, Sechenov University and Dept of Clinical Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Professor, Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. Dr Suchkov is a member of the: ● New York Academy of Sciences, USA ● American Chemical Society (ACS), USA; ● American Heart Association (AHA), USA; ● European Association for Medical Education (AMEE), Dundee, UK; ● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ● ARVO (American Association for Research in Vision and Ophthalmology); ● ISER (International Society for Eye Research); ● Personalized Medicine Coalition (PMC), Washington, DC, USA Dr Suchkov is a member of the Editorial Boards of “Open Journal of Immunology”, EPMA J., American J. of Cardiovascular Research and “Personalized Medicine Universe”

Personalized and Precision Medicine,Translational Medicine, Preventive Medicine

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

Prof. Dr. Carol Thomson, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Genetics, Virology and Immunology at California South University (CSU), Irvine, California, USA. He is a British scientist, who along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, co-discovered Hepatitis B in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of Hepatitis B led to the rapid development of diagnostic reagents to detect HCV in blood supplies which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide. Prof. Dr. Carol Thomson is currently America Excellence Research Chair in Virology and Li Ka Shing Professor of Virology at the California South University (CSU) where he is also Director of the Li Ka Shing Applied Virology Institute.

Genetics, Health Care, Medicine

Sergey Suchkov was born in the City of Astrakhan, Russia. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Inst of Med Enzymology. In 2001, and then his Doctor Degree at the Nat Inst of Immunology in Russia. From 1989 through 1995, was being a Head of the Lab of Clin Immunology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004 - a Chair of the Dept for Clin Immunology, Moscow Clin Research Institute (MONIKI). In 1993-1996, was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is: ● Professor, Director, Center for Personalized Medicine, Sechenov University and Dept of Clinical Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Professor, Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. Dr Suchkov is a member of the: ● New York Academy of Sciences, USA ● American Chemical Society (ACS), USA; ● American Heart Association (AHA), USA; ● European Association for Medical Education (AMEE), Dundee, UK; ● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ● ARVO (American Association for Research in Vision and Ophthalmology); ● ISER (International Society for Eye Research); ● Personalized Medicine Coalition (PMC), Washington, DC, USA Dr Suchkov is a member of the Editorial Boards of “Open Journal of Immunology”, EPMA J., American J. of Cardiovascular Research and “Personalized Medicine Universe”

Personalized and Precision Medicine,Translational Medicine, Preventive Medicine

XUE-QIAO ZHAO, is a Research Professor of Medicine and Director of Coronary Atherosclerosis Research Laboratory, University of Washington. She was a Senior Research Fellow, Cardiology, University of Washington, Seattle, WA, 1993. She was also Research Fellow, Cardiovascular Laboratory, Tulane University School of Medicine, New Orleans, LA, 1989. She was Chief Resident, Cardiology, Beijing Medical University, Beijing, China, 1988 and Cardiology Fellow, Beijing Medical University, Beijing, China, 1988. She was Resident in Internal Medicine, Beijing Post-Telecommunications Hospital, Beijing Medical University, Beijing, China, 1986.S he has completed MD, Beijing Medical University, Beijing, China, 1983.

Medicine

Dr. Masako Morishita is an Associate Professor in the Department of Family Medicine, College of Human Medicine at Michigan State University (MSU). She is an environmental exposure scientist, focused on improving physicochemical characterization of indoor/outdoor airborne particles, quantification of biomarkers of trace metals, and emission source identification – all of which is essential for toxicological and epidemiological studies in public health. Until recently she led exposure assessment tasks in the Great Lakes Air Center for Integrated Environmental Research (funded by USEPA), and directed the Trace Metals Laboratory for the University of Michigan Environmental Health Sciences Core Center (funded by NIEHS). She now directs the newly-constructed MSU Exposure Science Laboratory. She is currently the PI of an NINR R01 project, conducting a community-based intervention study focusing on the reduction of personal PM2.5 exposure and adverse cardiovascular responses. She received her B.S. in chemical engineering and her M.S. and Ph.D. in environmental health sciences from the University of Michigan.

Environmental Health Science, Preventive Medicine, Health Care

Dr. Farid Menaa is an inter- and multi-disciplinary professional with worldwide reputation. He has three international post-doctoral terms in Oncology, Dermatology, and Hematology; MBA Entrepreneurship and MD candidate. During his ongoing career, he has mainly contributed to the identification and functions of new human disease-causing genes and variants, formulated natural products for anti-aging and developed innovative theranostic strategies against cancers, cardiovascular diseases, diabetes, obesity and infectious diseases. He has more than 10 years’ experiences either in the academic, hospitals or industrial sectors. As Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. he actively participated in the development of the disruptive “Carbon-Fluorine Spectroscopy”. Dr. Menaa collaborates with various organizations worldwide. He is a member of several prestigious medical and scientific organizations and editorial boards in the field of medicine, science, technology and business, including in the nano-segment. He has authored more than 100 articles including research and review articles, books, book chapters, textbooks, proceedings, and has participated to over 200 scientific international events including as co-organizer, keynote speaker, chairman. Dr. Menaa’s worldwide collaborations, holistic point of view and strong expertise in various fields led him to prevent, implement early diagnosis, and develop efficient and safer therapy.

Dr. Farid Menaa’s research interest includes Preventive Medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Green Medicine, Nanomedicine, Biotechnology, and Nanotechnology.

Prof. Dr. Carol Thomson, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Genetics, Virology and Immunology at California South University (CSU), Irvine, California, USA. He is a British scientist, who along with Qui-Lim Choo, George Kuo and Daniel W. Bradley, co-discovered Hepatitis B in 1989. He also co-discovered the Hepatitis D genome in 1986. The discovery of Hepatitis B led to the rapid development of diagnostic reagents to detect HCV in blood supplies which has reduced the risk of acquiring HCV through blood transfusion from one in three to about one in two million. It is estimated that antibody testing has prevented at least 40,000 new infections per year in the US alone and many more worldwide. Prof. Dr. Carol Thomson is currently America Excellence Research Chair in Virology and Li Ka Shing Professor of Virology at the California South University (CSU) where he is also Director of the Li Ka Shing Applied Virology Institute.

Genetics, Health Care, Medicine

Sergey Suchkov was born in the City of Astrakhan, Russia. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD at the I.M. Sechenov Moscow Medical Academy and Inst of Med Enzymology. In 2001, and then his Doctor Degree at the Nat Inst of Immunology in Russia. From 1989 through 1995, was being a Head of the Lab of Clin Immunology, Helmholtz Eye Research Inst in Moscow. From 1995 through 2004 - a Chair of the Dept for Clin Immunology, Moscow Clin Research Institute (MONIKI). In 1993-1996, was a Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov, MD, PhD, is: ● Professor, Director, Center for Personalized Medicine, Sechenov University and Dept of Clinical Immunology, A.I.Evdokimov Moscow State Medical and Dental University; ● Professor, Chair, Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia ● Secretary General, United Cultural Convention (UCC), Cambridge, UK. Dr Suchkov is a member of the: ● New York Academy of Sciences, USA ● American Chemical Society (ACS), USA; ● American Heart Association (AHA), USA; ● European Association for Medical Education (AMEE), Dundee, UK; ● EPMA (European Association for Predictive, Preventive and Personalized Medicine), Brussels, EU; ● ARVO (American Association for Research in Vision and Ophthalmology); ● ISER (International Society for Eye Research); ● Personalized Medicine Coalition (PMC), Washington, DC, USA Dr Suchkov is a member of the Editorial Boards of “Open Journal of Immunology”, EPMA J., American J. of Cardiovascular Research and “Personalized Medicine Universe”

Personalized and Precision Medicine,Translational Medicine, Preventive Medicine

XUE-QIAO ZHAO, is a Research Professor of Medicine and Director of Coronary Atherosclerosis Research Laboratory, University of Washington. She was a Senior Research Fellow, Cardiology, University of Washington, Seattle, WA, 1993. She was also Research Fellow, Cardiovascular Laboratory, Tulane University School of Medicine, New Orleans, LA, 1989. She was Chief Resident, Cardiology, Beijing Medical University, Beijing, China, 1988 and Cardiology Fellow, Beijing Medical University, Beijing, China, 1988. She was Resident in Internal Medicine, Beijing Post-Telecommunications Hospital, Beijing Medical University, Beijing, China, 1986.S he has completed MD, Beijing Medical University, Beijing, China, 1983.

Medicine

Dr. Masako Morishita is an Associate Professor in the Department of Family Medicine, College of Human Medicine at Michigan State University (MSU). She is an environmental exposure scientist, focused on improving physicochemical characterization of indoor/outdoor airborne particles, quantification of biomarkers of trace metals, and emission source identification – all of which is essential for toxicological and epidemiological studies in public health. Until recently she led exposure assessment tasks in the Great Lakes Air Center for Integrated Environmental Research (funded by USEPA), and directed the Trace Metals Laboratory for the University of Michigan Environmental Health Sciences Core Center (funded by NIEHS). She now directs the newly-constructed MSU Exposure Science Laboratory. She is currently the PI of an NINR R01 project, conducting a community-based intervention study focusing on the reduction of personal PM2.5 exposure and adverse cardiovascular responses. She received her B.S. in chemical engineering and her M.S. and Ph.D. in environmental health sciences from the University of Michigan

Environmental Health Science, Preventive Medicine, Health Care